Formoterol ± tiotropium bromide reduces COPD exacerbations

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1558, 2006-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tiotropium bromide reduces cost burden, improves QOL in COPD

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Tiotropium bromide: setting new standards in COPD

Inpharma, Vol. 1, Iss. 1312, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD

By Cazzola M. Marco F.D. Santus P. Boveri B. Verga M. Matera M.G. Centanni S.

Pulmonary Pharmacology & Therapeutics, Vol. 17, Iss. 1, 2004-02 ,pp. : 35-39

Elsevier

Access to resources Recommend Favorite

Efficacy and Safety of Nebulized Formoterol as Add-on Therapy in COPD Patients Receiving Maintenance Tiotropium Bromide: Results from a 6-Week, Randomized, Placebo-Controlled, Clinical Trial

By Hanania Nicola A.

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1205-1216

Adis International

Access to resources Recommend Favorite

Tiotropium bromide lessens cost burden, improves QOL in COPD

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite